F752-0155 Screening compound: N~1~-[2-(5-chloro-1H-indol-3-yl)ethyl]-3-{[6-oxopyrido[2,3-e]pyrrolo[1,2-a]pyrazin-5(6H)-yl]methyl}benzamide

F752-0155 Screening compound: N~1~-[2-(5-chloro-1H-indol-3-yl)ethyl]-3-{[6-oxopyrido[2,3-e]pyrrolo[1,2-a]pyrazin-5(6H)-yl]methyl}benzamide
F752-0155 Screening compound: N~1~-[2-(5-chloro-1H-indol-3-yl)ethyl]-3-{[6-oxopyrido[2,3-e]pyrrolo[1,2-a]pyrazin-5(6H)-yl]methyl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F752-0155
N~1~-[2-(5-chloro-1H-indol-3-yl)ethyl]-3-{[6-oxopyrido[2,3-e]pyrrolo[1,2-a]pyrazin-5(6H)-yl]methyl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F752-0155

Molecular Formula

C28H22ClN5O2 (C28 H22 ClN5 O2)

Compound Name

N~1~-[2-(5-chloro-1H-indol-3-yl)ethyl]-3-{[6-oxopyrido[2,3-e]pyrrolo[1,2-a]pyrazin-5(6H)-yl]methyl}benzamide

IUPAC name

N-[2-(5-chloro-1H-indol-3-yl)ethyl]-3-({7-oxo-2810-triazatricyclo[7.4.0.0^{26}]trideca-1(13)35911-pentaen-8-yl}methyl)benzamide

SMILES

O=C(c1cc(CN(C2=O)c3ncccc3-n3c2ccc3)ccc1)NCCc1c[nH]c(cc2)c1cc2Cl

InChI

InChI=1S/C28H22ClN5O2/c29-21-8-9-23-22(15-21)20(16-32-23)10-12-31-27(35)19-5-1-4-18(14-19)17-34-26-24(6-2-11-30-26)33-13-3-7-25(33)28(34)36/h1-9,11,13-16,32H,10,12,17H2,(H,31,35)

InChI Key

UIYSYWVKGLXJPB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27189108

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

495.97

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.788

Distribution Coefficient, logD

4.788

Water Solubility, LogSw

-4.93

Polar Surface Area

61.422

Acid Dissociation Constant (pKa)

12.47

Base Dissociation Constant (pKb)

2.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

10.70

F752-0155 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

PLpro Library (6343 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Proteases
Mechanism of action:
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with F752-0155 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F752-0155?
Check Price and Availability of F752-0155, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F752-0155 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F752-0155
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F752-0155
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F752-0155 available by request